Beneficial Effect of Carbohydrate Maldigestion Induced by a Disaccharidase Inhibitor (AO-128) in the Treatment of Chronic Portal-Systemic Encephalopathy: A Double-Blind, Randomized, Controlled Trial

References

• Butterworth RF, Giguere JF, Michaud J, Lavoie J, Layrargues GP. Ammonia: key factors in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 1987;6:1–12.
   Google Scholar
• Zieve L, Doizaki WM, Zieve FJ. Synergism between mercaptans and ammonia and fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma. J Lab Clin Med 1974;83:16–28.
   Google Scholar
• Fischer JE, Baldessarini RJ. False neurotransmitters and hepatic failure. Lancet 1971;2:75–9.
   PubMed Web of Science ®Google Scholar
• Zerenoli ML. Hepatic encephatopathy. J Hepatol 1985;1:301–12.
   PubMedGoogle Scholar
• Sparhr L, Butterworth R, Fontaine SBL, Therrien G, Milette P, Lebrun L, et al. Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology 1996;24:1116–20.
   PubMedGoogle Scholar
• Uribe M. Treatment of portal systemic encephalopathy. The old and new treatments. In Grisolia S, editor. Cirrhosis, hepatic encephalopathy and ammonium toxicity. New York: Plenum Publishing Corp; 1991. p. 235–53.
   Google Scholar
• Ballongue J, Schumann C, Quignon P. Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scand J Gastroenterol 1997;32 Suppl 222:41–44.
   Google Scholar
• Uribe-Esquivel M, Moran S, Poo JL, Muñoz RM. In vitro and in vivo lactose and lactulose effects on colonic fermentation and portal-systemic encephalopathy parameters. Scand J Gastroenterol 1997;32 Suppl 222:49–52.
   Google Scholar
• Morgan MY, Hawley KE. Lactitol vs lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double blind, randomized trial. Hepatology 1987;7:1278–89.
   PubMedGoogle Scholar
• Morgan MY, Hawley KE, Stambuck D. Lactitol versus lactose in the treatment of chornic hepatic encephalopathy: a double blind randomized cross over study. J Hepatol 1987;4:236–44.
   Google Scholar
• Salminen S, Salminen E. Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection. Scand J. Gastroenterol 1997;32 Suppl 222:45–48.
   Google Scholar
• Greenberger NJ, Carley J, Schencker S, Bettenger I, Stamnes C, Bayer P. Effect of vegetable and animal protein diets in chronic hepatic encephalopathy. Am J Dig Dis 1977;22:845–55.
   PubMedGoogle Scholar
• Uribe M, Marquez MA, Garcia-Ramos G, Ramos-Uribe MH, Vargas F, Villalobos A, et al. Treatment of chronic portal systemic encephalopathy with vegetable and animal protein diets. A controlled crossover study. Dig Dis Sci 1982;27:1109–16.
   Google Scholar
• Keshavarzian A, Meek J, Sutton VM, Emery VM, Hughes EA, Hodson HJ. Dietary supplementation from vegetable sources in the management of chronic portal systemic encephalopaty. Am J. Gastroenterol 1984;79:945–9.
   PubMedGoogle Scholar
• DeBrujin KM, Blendis LM, Zilm DH, Carles PL, Anderson GH. Effect of dietary manipulations on subclinical portal systemic encephalopathy. Gut 1983;24:53–60.
   Google Scholar
• Uribe M, Dibildox M, Malpica S, Villalobos A, Nieto L, Vargas F, et al. Beneficial effect of vegetable protein diet supplemented with psyllium plantago in patients with hepatic encephalopathy and diabetes mellitus. Gastroenterology 1985;88:901–7.
   PubMed Web of Science ®Google Scholar
• Ladas SD, Frydas A, Papadopulos A, Raptis SA. Effects of alpha glucosidase inhibitors on mouth to cecum transit time in humans. Gut 1992;33:1246–8.
   PubMed Web of Science ®Google Scholar
• Goto Y, Yamada K, Ohyama T, Matsuo T, Odaka H, Ikeda H. An alpha-glucosidade inhibitor, AO-128, retards carbohydrate absorption in rats and humans. Diabetes Res Clin Pract 1995;28:81–7.
   PubMedGoogle Scholar
• Weber F, Banwell JG, Fresard KM, Cummings JH. Nitrogen in fecal bacterial, fiber and soluble fractions of patients with cirrhosis. Effects of lactulose and lactulose plus neomycin. J Lab Clin Med 1987;110:259–63.
   PubMed Web of Science ®Google Scholar
• Uribe M, Berthier JM, Lewis H, Mata JM, Sierra JG, García-Ramos G, et al. Lactose enemas plus placebo tablets vs neomycin tablets plus starch enemas in acute portal systemic encephalopathy: a double blind randomized controlled study. Gastroenterology 1981;81:101–6.
   Google Scholar
• Uribe M, Orozco H, Moran S, Guevara L, Poo JL, Vargas-Vorackova F. Portal systemic encephalopathy and gastrointestinal bleeding after cardioselective beta blocker (metoprolol) administration to patients with portal hypertension. Arch Med Res 1995;26:221–6.
   Google Scholar
• Horst D, Grace ND, Conn HO, Schiff E, Schenker S, Law D, et al. Comparison of dietary protein with an oral branched chain- enriched amino acid supplement in chronic, portal-systemic encephalopathy: double-blind controlled trial. Hepatology 1984; 4:279–87.
   PubMed Web of Science ®Google Scholar
• Riggio O, Balducci G, Ariosto F, Merli M, Pieche U, Pinto G, et al. Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt. Dig Dis Sci 1989;34:823–9.
   PubMedGoogle Scholar
• Marchesini G, Dioguardi FS, Bianchi GP, Zoli M, Bellati G, Roffi L, et al. Long-term oral branched-chain amino acid treatment in chronic encephalopathy. A randomised double-blind casein controlled-trial. J Hepatol 1990;11:92–101.
   Google Scholar
• Conn HO. Trailmaking and number connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 1977;22:541–50.
   PubMedGoogle Scholar
• Mondzac A, Ehrlich GE, Seegmiller JE. An enzymatic determination of ammonia in biological fluids. J. Lab Clin Med 1965; 66:526–31.
   PubMedGoogle Scholar
• Conn HO. Measurement of stool pH. In: Conn HO, Lieberthal HM, editors. Hepatic coma syndromes and lactulose. Baltimore (MD): Williams and Wilkins; 1979. p. 295–305.
   Google Scholar
• Rosado JL. Analisis de hidrogeno espirado como indice de absorcion de carbohidratos. Rev Inv Clin 1985;37:261–70.
   PubMedGoogle Scholar
• Hiller A, Plazin J, Van Slyke D. A study of conditions for Kjeldahl determination of nitrogen in protein. J Biol Chem 1948;176:1401–16.
   PubMed Web of Science ®Google Scholar
• Hiele M, Ghoos Y, Rutgeerts P, Vantrappen G. Effects of acarbose on starch hydrolysis. Study in healthy subjects, ileostomy patients, and in vitro. Dig Dis Sci 1992;37:1057–64.
   Google Scholar
• Uribe M, Campollo O, Cote C. Effect of lactulose on the metabolism of short-chain fatty acids. Hepatology 1990;12:1251–2.
   Google Scholar
• Mortensen PB, Holtug K, Bonnen H, Clausen MR. The degradation of amino-acids, proteins and blood to short-chain fatty acids in colon is prevented by lactulose. Gastroenterology 1980;98:353–60.
   Google Scholar
• Zillikerns MC, Swart GR, vand den Berg JW, Wilson JH. Effects of the glucosidase inhibitor acarbose in patient with liver cirrhosis. Aliment Pharmacol Ther 1989;3:453–9.
   Google Scholar
• Norgaard I, Hansen BS, Mortensen PB. Colonic fermentation of complex dietary carbohydrates in short-bowel patients. No association with hydrogen excretion and fecal and plasma short- chain fatty acids. Scand J Gastroenterol 1995;30:897–904.
   Google Scholar
• Vogelsang H, Ferenci P, Frotz S, Meryn S, Gangl A. Acid colonic microclimate-possible reason for false negative hidrogen breath test. Gut 1988;29:21–6.
   Google Scholar